Icad Inc Stock Investor Sentiment

ICAD Stock  USD 2.04  0.07  3.55%   
About 54% of Icad's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding icad inc suggests that some traders are interested. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
  

Icad Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at gurufocus.com         
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial ...
Gurufocus Stories at Macroaxis
over a week ago at globenewswire.com         
CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions ...
Macroaxis News: globenewswire.com
over a week ago at finance.yahoo.com         
CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions ...
Yahoo News
over a week ago at gurufocus.com         
CORRECTION -- iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI ...
Gurufocus Stories at Macroaxis
over two weeks ago at globenewswire.com         
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Secon...
Macroaxis News: globenewswire.com
over two weeks ago at gurufocus.com         
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a ...
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
iCAD, Inc. Sees Significant Growth in Short Interest
news
over three weeks ago at finance.yahoo.com         
Need To Know Analysts Just Made A Substantial Cut To Their iCAD, Inc. Estimates
Yahoo News
over three weeks ago at thelincolnianonline.com         
iCAD Cut to Sell at StockNews.com
news
over three weeks ago at insidermonkey.com         
iCAD, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over three weeks ago at investing.com         
Earnings call iCAD reports steady growth with SaaS transition
Investing News at Macroaxis
over three weeks ago at gurufocus.com         
icad Inc Q3 2024 Earnings Call Highlights Revenue Growth Amidst Strategic Shifts
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
iCAD Inc Reports Q3 2024 Revenue of 4.2 Million, EPS Loss of 0. ...
Gurufocus Stories at Macroaxis
over three weeks ago at seekingalpha.com         
iCAD Non-GAAP EPS of -0.07 beats by 0.01, revenue of 4.2M misses by 0.42M
seekingalpha News
over three weeks ago at finance.yahoo.com         
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
Yahoo News
Far too much social signal, news, headlines, and media speculation about Icad that are available to investors today. That information is available publicly through Icad media outlets and privately through word of mouth or via Icad internal channels. However, regardless of the origin, that massive amount of Icad data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icad alpha.

Icad Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
iCAD to Participate in the LD Micro Main Event XVII
10/16/2024
2
3 US Penny Stocks With Market Caps At Least 40M To Watch
10/22/2024
3
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
11/05/2024
4
FDA clears AI-powered breast cancer detection tech from iCad
11/12/2024
5
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
11/13/2024
6
iCAD, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
7
iCAD, Inc. Sees Significant Growth in Short Interest
11/19/2024
8
CORRECTION -- iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI ...
12/04/2024
9
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial ...
12/11/2024

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios